NMVO on-boarding presentation

Similar documents
EMVO ON-BOARDING HOW TO CONNECT TO THE EU HUB? VERSION OCTOBER 2017

The Blueprint approach

FMD Implementation Status Report

The European Stakeholder Model A Medicines Verification System for Europe (ESM)

FMD Implementation Status Report

Verification processes in the supply chain. Workshop for MAHs, Helsinki, 18 Sep 2018 Teijo Yrjönen, FiMVO

HI, emvo. Author's Signature. Approver's Signature. ROnoMnP TO NMVO AND NMVS IUPITUENTATION. Interim General Manager. Interim Quality Assurance

Guideline for EMVO and NMVO stakeholders: recommendations for alert handling and prevention process. January 2019

EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update

Falsified Medicines Directive: Irish Medicines Verification Organisation (IMVO) update for HPRA GMP Conference LEONIE CLARKE - 7 TH FEBRUARY 2017

Project responsibilities

EU Falsified Medicines Directive. Gareth Jones

FIMVO END USER AND ISV WORKSHOP. Paul Mills - EMVO

MAHs and CMOs considerations and objectives to meet upcoming regulations in 2019

FMD error and alert messages guidance notes To accompany FMD scanning and alert messages chart (v7) December 2018 UPDATED GUIDANCE

EMVO FMD Workshop Brussels 13. December 2016

The Journey

National Blueprint System Slovakia Kick-Off Meeting

National Blueprint System Slovakia Kick-Off Meeting

The value partnership between NHS, industry and other providers

GS1 Ireland Healthcare User Group (HUG) Information Day

IT Provider Workshop for the EMVS NBS

Odoo Enterprise Subscription Agreement

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs

Falsified Medicines Directive: Overview from the Irish Medicines Verification Organisation (IMVO) LEONIE CLARKE - 28 TH MARCH HUG

FMD edusammud ja väljakutsed. Mai 26, 2017 Tartu. Ravimiameti infopäev. Mart Levo REKS Eesti.

Inside EU FMD and the Delegated Acts A Compliance Primer

Implementation of the safety features in medicinal products for human use

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY 26 FEBRUARY 2016

Customer Success Packages

GS1 CLOUD BRAND OWNER TERMS OF PARTICIPATION

PLAINSCAPITAL BANK APPLE PAY TERMS AND CONDITIONS - BUSINESS

Safety features for medicinal products for human use. Questions & Answers. 1. Document history

The Falsified Medicines Directive. What pharmacy teams need to do

Manufacturers serialisation challenges with FMD & DR implementation

Implementation of the safety features in medicinal products for human use

Health systems and products Medical products quality, safety and innovation VERSION 8

European Medicines Verification Organisation: Requirements for the European Medicines Verification System URS Lite

Low-Level Design Validation and Testing

What To Do or Not To Do? Utility of Medication Traceability to the Patient

DEVELOPING APPLICATIONS USING MICROSERVICES AND MICROSOFT AZURE SERVICE FABRIC 1

Serialisation. GS1 Standards in Healthcare. Standards Certification Education & Training Publishing Conferences & Exhibits

Jerome Lepeintre. Delegation of the European Union to China and Mongolia

The new European Regulations the Importance of GS1 standards in the Healthcare sector

General Terms of Purchase

Safety Features Required by the Falsified Medicines Directive 2011/62/EU

The role of the European Commission during the FMD implementation phase Agnès Mathieu DG SANTE European Commission

Falsified Medicines Directive Procedure for managing Alerts generated by the verification system

Top 15 Questions and Answers. EU FMD Safety Features and Verification

Falsified Medicines Directive Info session for MAHs

The way forward for FMD in community pharmacy

Process and Architecture Overview IDMP Identification of Medicinal Products. Sven Eller, Life Sciences Solution Engagement Manager

Background to the Falsified Medicines Directive and the Delegated Regulation. Susan Grieve, Principal Pharmacist, Department of Health 12 April 2016

Evaluation of Counterfeit Cases Impact of FMD & GDPs. Lorraine Nolan Healthcare Products Distribution Manager

By agreeing to these Terms and Conditions, you represent the following:

European Union (EU) Falsified Medicines Directive

SPECIFIC CONDITIONS OF ISO/TS CERTIFICATION SERVICES

Verification of Pharmaceutical Products at the Point of Dispense. An EFPIA update

Project Status. Tero Vesa Technical project manager, FiMVO

Update Version 1.0 Based on the information available at that date of NCA.

Safety features for medicinal products for human use

Odoo Partnership Agreement

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents

QSS 0 Products and Services without Bespoke Contracts.

ACCOUNTABILITY AND TRANSPARENCY IN PHARMA SUPPLY CHAIN 6/26/2018. Presentation to UN 2018 Public Service Forum. Richard Bergström External Lead Pharma

GS1 Ireland Healthcare User Group (HUG) Information Day

SAP Online Knowledge Products (OKP) Rapid Deployment Solutions

Belgian Medicines Verification Organisation. End User Implementation

Changes to the MCR &Tips for Implementation: The Minimum Competency Code 2011 Lisa Knox Enterprise Risk Services 17 November 2011

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide.

A closer look at the EU- FMD Safety Features Delegated Act: 10 things pharma manufacturers need to consider

Service Description: Dell Asset Resale and Recycling Services - IT Asset Recycling

Additional Terms & Conditions for Use of Apple Pay to Supplement Your Interactive Brokers Debit Mastercard Cardholder Agreement

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

Practical implementation of the Falsified Medicines Directive

Terms of Trade GENERAL SELLER S OBLIGATIONS. Terms of Trade web-parts.com, 7. March is owned by

Pakistan Identity Federation Policy

Regulatory Update. Paul Sexton. QP Forum

Regulating risks of falsified medicinal products in the legal distribution chain Safety features - Legal and Regulatory issues

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

ISCC 204 AUDIT REQUIREMENTS AND RISK MANAGEMENT. Version 3.0

ARTICLE 29 DATA PROTECTION WORKING PARTY

The interface between Good Clinical Practice and Good Manufacturing Practice

GAMP5 Validation for Dynamics 365

Chain of Custody Standard

V.) FedEx Trade Networks shall not be liable for any delay or loss of any kind, which occurs while a shipment is in the custody or control of a Third

Lithonia Lighting Terms and Conditions of Sale

Quality & Validation for the Supply Chain

Cargotec Supplier Requirements

Falsified Medicines Directive Procedure for managing Alerts generated by the verification system

UKAS Supplement for the Accreditation of Environmental Verifiers for EMAS (the EU Eco Management and Audit Scheme Regulation 1221/2009)

This document has been provided by the International Center for Not-for-Profit Law (ICNL).

New GDP Guidelines - Implementation

FedEx. Packaging. Rev. 11/11

Delegated Act on the detailed rules for a unique identifier for medicinal products for human use, and its verification

The APIC Audit Programme Version 5, July 2017

RENU Identity Federation (RIF)

General Retention and Disposal Authority: GA28

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Transcription:

NMVO on-boarding presentation Please check https://www.emvo-medicines.eu/ for the latest version of this presentation and the on-boarding guideline. European Medicines Verification Organisation (EMVO) www.emvo-medicines.eu helpdesk@emvo-medicines.eu Version 3.0 dd/mm/yyyy 27 October 2017 1

DISCLAIMER 2

Content General Information NMVO on-boarding & QA goals Cooperation Agreement with EMVO System Assessment & Technical on-boarding Quality Assurance Audit 3

Content General Information NMVO on-boarding & QA goals Cooperation Agreement with EMVO System Assessment & Technical on-boarding Quality Assurance Audit 4

FMD Legislation and Delegated Act Establish National Systems in 32 countries Connect approx. 2,500 On-boarding Partners (OBPs) to the EU Hub Connect many thousand Pharmacies and Wholesalers Serialise all affected pharmaceutical packs (10.5 bn) 2011 2017 2018 2016 2017 2018 2019 July 2011 Publication of FMD FMD: Falsified Medicines Directive 9 Feb 2016 Publication of Delegated Regulation 36 Mon 9 Feb 2019 Mandatory verification of all packs in scope ~ 330 working days remain 5

Responsibilities of the Supply Chain Partners Serialization by MAH Risk based verification by Wholesalers Verification and check-out at point of dispense Safety features: Code ( unique identifier ) + Tamper evidence System set up and Governance by MAH together with other stakeholders Oversight by competent authorities NMVS Product #: 09876543210982 S/N: 12345AZRQF1234567890 Batch: A1C2E3G4I5 Expiry: 140531 HUB 6

EMVO Members Pharmacies Wholesalers Hospitals Parallel Distributors Research Based Industry Generics Industry 7

Organisational Chart EMVO Board of Directors President: Hugh Pullen (EFPIA) Vice-President: Sonia Ruiz Morán (PGEU) Treasurer: Richard Freudenberg (EAEPC) Monika Derecque-Pois (GIRP) Adrian van den Hoven (Medicines for Europe) 8

System Landscape I 9

System Landscape II OBP OBP NMVO OBP: On-boarding Partner NMVS: National Medicines Verification System NMVO: National Medicines Verification Organisation 10

Content General Information On-boarding process & QA goals Cooperation Agreement with EMVO System Assessment & Technical on-boarding Quality Assurance Audit 11

NMVO on-boarding process Implementation Phase 9/2/2019 Operational Phase Start Contract NMVO - EMVO System assessment Pilot Technical onboarding Rampup Contract with IT service provider signed Negotiate & sign off the Cooperation Agreement - System capability assessed by EMVO on QMS processes and SPOC assignment (Part 1) - System connection to EMVO IQE - UAT & Cert. test witnessed and assessed by EMVO (Part 2) - System connection to productive environment - Technical golive Controlled onboarding of End- Users All End Users onboarded Quality Assurance Audits Quality Assurance goals : QA person assigned Set-up QMS @ NMVO Ensure QMS @ IT service provider Ensure a validated NMVS System operation QMS implemented EMVO not involved EMVO involved 12

Content General Information On-boarding process & QA goals Cooperation Agreement with EMVO System Assessment & Technical on-boarding Quality Assurance Audit 13

Organisation prerequisites NMVS must be governed and managed by a national stakeholder organisation (NMVO) Alignment between all stakeholders NMVO statutes agreed NMVO established non-profit legal entity compliant with DR Article 31 NMVS: NMVO: DR: National Medicines Verification System National Medicines Verification Organisation Delegated Regulation 14

NMVO contract landscape EMVO Cooperation Agreement NMVO Frame Contract EU Hub Service Contract Solidsoft Service provider support agreement IT service provider EMVO: Solidsoft: NMVO: IT service provider: European Medicines Verification Organization IT service provider for implementation and operation of EU Hub National Medicines Verification Organisation IT service provider of the NMVS (e.g. one of the Blueprint suppliers) 15

Purposes of Cooperation Agreement Contractual framework for the cooperation between EMVO and NMVO during the EMVS Implementation Phase. Set the parties respective rights and obligations in relation to the : Development, implementation, testing and operation of the NMVS in line with the EMVS URS as provided by EMVO Connection between the EU Hub and the NMVS Use of the EU Hub and NMVS to transfer data between them Target is to allow End Users to verify authenticity of medicines in accordance with Falsified Medicines Directive and Delegated Regulation latest on the 9 th of February 2019 As part of the Implementation Phase it is agreed that the EMVS or any of its components may be substantially changed or amended. 16

Parties for the Agreement 1. European Medicines Verification Organisation A.S.B.L. at 1040 Brussels Belgium ( EMVO ) 2. National Medicines Verification Organisation ( NMVO ) the legal non for profit organisation of that country In case of a national two tier structure: 3. Affiliate of the NMVO (bound jointly and severally with the NMVO) e.g. operational ltd. All involved parties are directly bound to the provisions of the agreement 17

System security Protection of the system security is one of the guiding principles that shapes the agreement The parties shall implement state-of-the-art security measures and at least the security measures as requested in the SDK Strict confidentiality for SDK and other confidential information, provided only on need to know basis Use of SDK restricted to the purposes of the agreement Each party has the right to disconnect the NMVS from the EU Hub in case it believes that the NMVS immediately or substantially endangers the security or functioning the EMVS in whole or in part Exchange of reports on a regular basis Legitimacy checks and control for all system users in accordance with Falsified Medicines Directive (FMD) and Delegated Regulation 18

Security breach In order to handle a security breach in a cooperative manner, a procedure is foreseen: Information within 24 hours after awareness Cooperation in investigation Take all measures to solve the issue Take all measures to mitigate the consequences Take all measures to prevent reoccurrence If required by applicable law Notification of public authorities or individuals Undertake remedial actions 19

EMVO s Main Obligations Develop and operate the EU Hub for the purposes in accordance with FMD and Delegated Regulation Provide documentation and SDK for the development and use of the EU Hub-NMVS interface Provide a contact person for this agreement Provide information about key facts, project status and project progress on EU Hub interface development Undertake best efforts to provide EU Hub functionality in a diligent manner and to protect it with state-of-the art security measures Provide copy of insurance, if any 20

NMVO s Main Obligations Develop and operate the NMVS for the purposes, in accordance with the SDK, the agreement and FMD and Delegated Regulation Protect its NMVS with state-of-the-art security measures (and at least the security measures set forth under the SDK). Ensure that its IT service provider is subject to equivalent obligations Carry out legitimacy check and ensure that End Users are held with appropriate terms to use the EMVS Provide a contact person for this agreement Be responsible towards EMVO for activities carried out on its NMVS Provide copy of insurance, if any 21

Limitation of Warranty and Liability The guiding principle is a back to back provision that : Excludes implied warranties; the EU Hub and NMVS are provided as is Excludes indirect or consequential damages Allows a party to recover direct damages from the other party (provided that the other party can itself recover such damages from its IT service provider to the extent it relates to a breach of its obligations by such IT service provider in relation to the design, builds, test and deployment of the EU Hub/NMVS) Excludes EMVO s liability for inaccurate, incomplete or corrupted data, or any malicious software The liabilities of all parties will be capped on a level of 20K Euro. 22

Termination of the agreement Automatic expiration on 8 th of February 2019 Mutual extension by way of amendment possible for the Operational Phase EMVO to make suggestion for extension of provisions latest 9 months before automatic expiration (see next 2 slides on contract extension) The agreement can be dissolved by either party Breach of material obligation under the DR Change of legislation affecting the capacity of a party to operate the EU Hub or the NMVS If the other party looses its competence to act in its role 23

General approach to contract extension Starting Point: Template for the EMVS Implementation Phase Working Group: Representatives from some selected Countries and from EMVO Lead of the Working Group: EMVO Selection of Country Representatives: EMVO Stakeholders Target: Develop Contract Template for Operational Phase that works for all parties until end of Q1 in 2018 24

Milestones in Reference Schedule to establish the contract extension Year 2017 Q 2 Q 3 Q 4 2018 Q 2 Q 3 Q 4 2019 1 2 1 2 3 1 2 3 4 Manufacturer Onboarding Connected to HUB (CH) Products serialized + uploaded (PS) NMVO Operation Funding secured (Funding) Team implemented (Team) Initial Tasks completed (Tasks) National Pilot Technical Implementation started (TIS) Prerequisites + Pilot defined (PD) First Products verified (FP) Pilot sucessfully completed (PC) National Ramp Up 25% 50% 75% 100% For Pilot 25% 50% 75% 100% Selection of Country Representatives complete Working Group Kick Off First Draft Published Final Draft Published 1 2 End User Systems connected + live (SY) End Users connected + live (EC) For Pilot 25% 50% 75% 100% 25% 50% 75% 100% 25

Disclaimer for this chapter This presentation is provided for information purposes only and is not binding EMVO in any manner. It only provides a general overview of the main provision of the Cooperation Agreement, which should not be regarded as exhaustive. Only the Cooperation Agreement signed by EMVO s representation will bind EMVO. The Cooperation Agreement and this presentation may still be revised and adapted. [No warranty of any kind is made or given by EMVO including, but not limited to, the accuracy or the completeness thereof. To the fullest extent permitted by applicable law, EMVO expressly disclaims all warranties of any kind, whether expressed or implied, including, but not limited to the warranties for hidden or latent defect, of merchantability, fitness for a particular purpose and non-infringement. EMVO shall not be liable for any direct or indirect damage, loss or claims, including loss of use, data, profits, benefits, data, business, opportunity, goodwill, clientele, for third party s claims, or for any other indirect, special, incidental or consequential damages of any kind in connection with or arising out of the use of any information disclosed hereunder, whether alleged as a breach of contract (including grave fault), tort, negligence (including gross negligence), hidden/latent defects, strict liability or any other legal theory, even if the EMVO had been advised of the possibility of such damage. Nothing herein shall, however, operate to limit or exclude any liability for fraud or other liability that cannot be legally excluded. EMVO reserves the right to amend this presentation at any time without prior notice. ] 26

Content General Information On-boarding process & QA goals Cooperation Agreement with EMVO System Assessment & Technical on-boarding Quality Assurance Audit 27

System assessment System assessment - System capability assessed by EMVO on QMS processes and SPOC assignment (Part 1) (*) Exception as of 2nd implementation of the same Blueprint supplier possible 28

System assessment (part 1) The system assessment part 1 will ensure that: The NMVO meets minimum expectations for: Financial stability; Information security management; Roles and responsibilities; End User legitimacy check; On-boarding process; Access management; Incident management; Change management. A Single Point of Contact (SPOC) is assigned 29

Technical on-boarding Technical on-boarding - System connection to EMVO IQE - UAT & Cert. test witnessed and assessed by EMVO (Part 2) - System connection to productive environment - Technical go-live 30

NMVS: from development to technical go-live (v2.0) Development ITAT System assessment part 1 UAT + System Assessment part 2 Technical go-live IT service provider controled EMVO involvment NMVS environment(s) required for the development stage NMVS_A NMVS_A NMVS software IT-E ITAT-E NS IQE (UAT & Cert.Test) NS PRD EU Hub Dedicated EU HubTest Environment(s) controlled by the IT service provider as rented from Solidsoft - Reply EMVO IQE (Cert.Test) EMVO PRD 31

Technical on-boarding of NMVS Starts after a positive system assessment part 1 NMVS IQE will be connected to EMVO IQE to execute the NMVS UAT and certify the interface Assessment Part 2 (See next slide) NMVS PRD will be connected to EMVO PRD Note: Exchange of certificate information is identical for EMVO IQE and EMVO PRD NMVO creates CSR file Solidsoft signs CER certificate IT service provider to provide connection 32

System assessment (part 2) The NMVS is meeting the EMVS requirements - The UAT- test report, external security audit and traceability matrix will act as input for the system assessment. - Both functional- and non-functional requirements are in scope. - System assessment part 2 will be processed during and after the UAT. 33

Assessments and expenses As per Cooperation Agreement, the NMVO will : support these assessments with all reasonably necessary means. bear the costs of these assessments Average assessment effort is expected to amount to 12.500 EUR per NMVO. All EMVO assessment efforts will be charged under Time & Material, including hours of staff/experts and travel expenses. EMVO will provide a costs estimate to the NMVO in advance. 34

Planning of System Assessment, and Technical on-boarding Minimum 5 weeks before the UAT, the NMVO has to: Request the preferred UAT and Go-live timeslots 1. Check the availabilities in the UAT planner (available on the Sharepoint) 2. Send the requested UAT and Go-live dates and the NMVO SPOC to helpdesk@emvo-medicines.eu 3. EMVO will book the dates in the UAT planner Provide documentation for assessment part 1 Planning constraints: Resource availability Maximum 1 UAT per week Before UAT and the assessment of part 1, the Cooperation Agreement has to be concluded between NMVO and EMVO 35

Content General Information On-boarding process & QA goals Cooperation Agreement with EMVO System Assessment & Technical on-boarding Quality Assurance Audit 36

Quality Assurance QA person assigned Set-up QMS @ NMVO Ensure QMS @ IT service provider Ensure a validated NMVS Quality Assurance goals 37

QA person assigned Quality Assurance goals QA readiness of NMVO / NMVS is not an EMVO prerequisite for on-boarding Each system owner is responsible for the validation of his system EMVO for the EU hub Each NMVO for its NMVS 38

Set-up QMS of NMVO For Blueprint model based countries: EMVO provides QA templates free of charge The tailoring of the QMS to the specific NMVO organisation is to be managed by the NMVO Tailoring service for Blueprint model based countries may be provided by EMVO and are subject to payment 39

Ensure QMS @ IT service provider EMVO performed audits at all Blueprint supplier s and are as such approved to have the ability. Exact operating procedures to be agreed on NMVO level IT service providers are to be audited by NMVO to ensure their QMS meets Quality expectations 40

Content General Information On-boarding process & QA goals Cooperation Agreement with EMVO System Assessment & Technical on-boarding Quality Assurance Audit 41

Audits Audits System Operation QMS implemented 42

Purpose: Audit purpose & objective To verify that the NMVS, its system operation and support processes comply with: EMVO quality standards Regulation Objectives To verify the capability to operate the system in a validated status Achieve high degree of confidence that NMVS will perform as intended Ensure QMS of IT service provider meets EMVO Quality expectations Ensure that NMVO complies to Article 31 of the DR and is financially stable 43

Audit Applicable Regulation & Best Practices Directive 2011/62/EU and Delegated Act GAMP5: A Risk-Based Approach to Compliant GxP Computerized Systems Eudralex Volume 4 and Annexes (e.g. Annex 11, Annex 15) ISO/IEC 27001: 2013 lnformation security management systems ISO/IEC 27002: 2013 Code of practice for information security management ISO/IEC 27005: lnformation security risk management. ISO/IEC 38500: lnformation Technology Governance ISO/IEC 20000: lt service management 44

Audit focus i.a. URS compliance with DR System design and architecture compliance with DR Interface with EU Hub developed according to EMVS specification (EMVS URS & SDK) Data integrity, access and ownership Compliance of NMVO to Article 31 of the DR Risk assessments QMS procedures, incl. : the on-boarding procedure for end-users (to ensure compliance with DR Article 37(b) ) Legitimacy check of end-users & potentially manufacturers (if applicable) 45

Audit minimum requirements to QMS QMS deliverable implemented SOP template Form Template NMVO controlled document list Document management Validation policy Validation plan template Validation report template User requirements specification template Roles and Responsabilities Risk management Risk assessment template Information security management QMS manual Initial system assessment template Test management Release and deployment management QMS deliverable implemented Change management Change request template Training management Training registration form template QMS Training requirements Access management Onboarding process User requirements specification Incident management Incident investigation report template CAPA management CAPA Form Audit management Complaint management Business continuity management 46